TScan Therapeutics Inc., a clinical-stage biotechnology company specializing in T cell receptor-engineered T cell therapies for cancer treatment, will present at the Jefferies Global Healthcare Conference. The event is scheduled for June 4, 2025, at 4:55 p.m. Eastern Time at the Marriott Marquis in New York, NY. A webcast of the presentation will be accessible on the company's website.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.